Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Cardiovascular Events, Stroke, and Mortality in Patients with Type 2 Diabetes

被引：0
作者：
Kawada, Tomoyuki [1 ]
机构：
[1] Nippon Med Sch, Dept Hyg & Publ Hlth, 1 1 5 Sendagi Bunkyo Ku, Tokyo 1138602, Japan
来源：
CARDIOVASCULAR DRUGS AND THERAPY | 2023年 / 37卷 / 04期
关键词：
OUTCOMES;
D O I：
10.1007/s10557-022-07374-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：619 / 620
页数：2
相关论文
共 50 条
  • [21] Plausible prediction of renoprotective effects of sodium-glucose cotransporter-2 inhibitors in patients with chronic kidney diseases
    Berezin, Alexander E.
    Berezina, Tetiana A.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (02)
  • [22] Safety outcomes of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and other risk factors for cardiovascular disease: a systematic review and meta-analysis
    Deshpande, Radhika
    Patel, Raj
    Regmi, Manjari R.
    Salih, Mohsin
    Kropp, Robert
    Al-Bast, Basma
    Sheikh, Muhammad A.
    Sagalov, Andrew
    Kulkarni, Abhishek
    Siddique, Momin
    Hegde, Shruti
    Bhattarai, Mukul
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2023, 12 (02) : E0284
  • [23] Performance of sodium-glucose cotransporter 2 inhibitors in cardiovascular disease
    Khater, Jacinthe
    Malakouti, Sara
    El Khoury, Antoine
    Cortese, Bernardo
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2024, 25 (04) : 247 - 258
  • [24] Lipid effects of sodium-glucose cotransporter 2 inhibitors
    Lazarte, Julieta
    Kanagalingam, Tharsan
    Hegele, Robert A.
    CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (03) : 183 - 190
  • [25] Mechanisms of cardio-renal protection of sodium-glucose cotransporter-2 inhibitors
    Chiriaco, Martina
    Trico, Domenico
    Solini, Anna
    CURRENT OPINION IN PHARMACOLOGY, 2022, 66
  • [26] Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure: The New Kid on the Block
    McDermott, Jaime
    Tennyson, Carolina
    Bell-McClure, Elizabeth
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2021, 17 (06): : 652 - 656
  • [27] A New Hope in Type 2 Diabetes Mellitus Management: Sodium-Glucose Cotransporter 2 Inhibitors
    Chaurasia, Pallavi Prakash
    Dholariya, Sagar
    Kotadiya, Fenilkumar
    Bhavsar, Milav
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [28] Timing and Adherence Matter for Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure
    Yilmaz, Mehmet Birhan
    Celik, Ahmet
    Sahin, Anil
    Colluoglu, Tugce
    Ural, Dilek
    Kanik, Arzu
    Ata, Naim
    Ulgu, Mustafa Mahir
    Birinci, Suayip
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2025, 14 (07):
  • [29] Effect of Sodium-Glucose Cotransporter Inhibitors on Major Adverse Cardiovascular Events and Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus and Atrial Fibrillation
    Kwon, Chang Hee
    Kim, Ye-Jee
    Kim, Min-Ju
    Cha, Myung-Jin
    Cho, Min Soo
    Nam, Gi-Byoung
    Choi, Kee-Joon
    Kim, Jun
    AMERICAN JOURNAL OF CARDIOLOGY, 2022, 178 : 35 - 42
  • [30] Sodium-glucose cotransporter 2 inhibitors and cardiovascular events among patients with type 2 diabetes and low-to-normal body mass index: a nationwide cohort study
    Mori, Yuichiro
    Komura, Toshiaki
    Adomi, Motohiko
    Yagi, Ryuichiro
    Fukuma, Shingo
    Kondo, Naoki
    Yanagita, Motoko
    Duru, O. Kenrik
    Tuttle, Katherine R.
    Inoue, Kosuke
    CARDIOVASCULAR DIABETOLOGY, 2024, 23 (01)
12345